迪安诊断 (300244)
DIAN DIAGNOSTICS GROUP CO.,LTD.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 62497.94
- Circulating A-Shares(W): 50145.91
- Earnings Per Share(RMB): 0.0928
- Net Assets Per Share(RMB): 10.3519
- Operating Revenue(W RMB): 756558.67
- Total Profit(W RMB): 27608.91
- Net Profit Attributable to Parent(W RMB): 5670.48
- Net Profit Growth Rate(%): -56.67
- Weighted Return on Equity(%): 0.8700
- Operating Cash Flow Per Share(RMB): 1.3950
- Undistributed Profit Per Share(RMB): 6.2941
- Capital Reserve Per Share(RMB): 2.9324
2. Main Business
The main business covers:
- Medical diagnostic services
- Diagnostic technology R&D
- Diagnostic product manufacturing and sales
- Judicial expertise
- Health management
3. Company Basic Information
- Company Name: Dian Diagnostics Group Co., Ltd.
- Listing Date: 2011-07-19
- Industry: Medical & Healthcare - Medical Services
- Address: 5th Floor, Building 2, No. 329 Jinpeng Street, Sandun Town, Xihu District, Hangzhou City, Zhejiang Province
- Website: www.dazd.cn
- Company Profile: The company was established as a joint stock company on May 12, 2010, through the overall transformation of Dian Co., Ltd. The promoters include Mr. Chen Haibin, Shanghai Fosun, Tianjin SoftBank, Mr. Hu Yong, Ms. Xu Min, and Ms. Lai Cuiying. On January 20, 2010, a shareholders' meeting resolved to transform Dian Co., Ltd. into a joint stock company. The audited net assets of RMB 82,968,000 as of December 31, 2009, were converted into 36 million shares with a par value of RMB 1 per share, and the remaining RMB 46,968,000 was recorded as capital reserve. On May 5, 2010, Lixin Certified Public Accountants issued the Xinhui Shi Bao Zi (2010) No. 24084 "Capital Verification Report," confirming the capital contribution of the joint stock company. On May 12, 2010, the Hangzhou Administration for Industry and Commerce issued the "Business License" (Registration No. 330106000013053) to the company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hangzhou Dian Holding Co., Ltd. | General Legal Person | 1063.64 | 2.12 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1056.35 | 2.11 |
| 3 | Southern China Securities 1000 ETF | Fund | 456.88 | 0.91 |
| 4 | Abu Dhabi Investment Authority - Proprietary Account | QFII | 427.03 | 0.85 |
| 5 | Yongying CSI All Share Medical Devices ETF | Fund | 308.75 | 0.62 |
| 6 | Wanjia Health Industry Hybrid Securities Investment Fund Class A | Fund | 22.20 | 0.04 |
5. Concept Sectors
- Infant & Child Concept
- Belt and Road Initiative
- Elderly Care Concept
- Vocational Education
- Gene Concept
- Immunotherapy
- Alibaba Concept
- Artificial Intelligence
- CXO Concept
- Cold Chain Logistics
- Assisted Reproduction
- Hepatitis Concept
- AIGC Concept
- ChatGPT
- Data Elements
- Multimodal AI
- AI Agent
- DeepSeek
- AI Healthcare
- Margin Trading & Securities Lending
- Low-Profit Stock
- QFII Heavy Holdings
- CCTV 50
- ChiNext 300
- ChiNext Blue Chips
- ChiNext Healthcare
- ChiNext Small Cap
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information